Cargando…
SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF
The prognosis of breast cancer brain metastasis (BCBM) is extremely poor due to its resistance to conventional therapy. Elucidation of the molecular mechanisms of BCBM could contribute to the development of new therapeutic targets. In this study, we isolated RNA samples from primary breast cancer or...
Autores principales: | Xiao, Weikai, Zheng, Shaoquan, Xie, Xinhua, Li, Xing, Zhang, Lijuan, Yang, Anli, Wang, Jian, Tang, Hailin, Xie, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163054/ https://www.ncbi.nlm.nih.gov/pubmed/32322668 http://dx.doi.org/10.1016/j.omto.2020.03.001 |
Ejemplares similares
-
CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
por: Xiao, Weikai, et al.
Publicado: (2019) -
Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study
por: Xiao, Weikai, et al.
Publicado: (2018) -
Incidence and Survival Outcomes of Breast Cancer with Synchronous Hepatic Metastases: A Population-Based Study
por: Xiao, Weikai, et al.
Publicado: (2018) -
Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population‐based study
por: Xiao, Weikai, et al.
Publicado: (2018) -
Prognostic value of chronic hepatitis B virus infection in patients with breast cancer in a hepatitis B virus endemic area
por: Xiao, Weikai, et al.
Publicado: (2020)